GLMD Stock Analysis: Buy, Sell, or Hold?
GLMD - Galmed Pharmaceuticals Ltd.
$0.62
0.00 (0.65%)
â˛
5d:
+31.26%
30d:
-6.45%
90d:
-0.44%
WAIT
LOW Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Jun 18, 2026
1d
Get Alerted When GLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GLMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GLMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: GLMD is currently trading at $0.62, which is considered fair relative to its 30-day fair value range of $0.56 to $0.68.
Technical Outlook: Technically, GLMD is in a downtrend. Immediate support is located at $0.41, while resistance sits at $0.79.
Market Sentiment: GLMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.00 (+1848.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GLMD is in a downtrend. Immediate support is located at $0.41, while resistance sits at $0.79.
Market Sentiment: GLMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.00 (+1848.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.56 -
$0.68
Company Quality Score
41/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 1848.1% below Wall St target ($12.00)
Trading Range Analysis
30-Day Trading Range
$0.56 -
$0.68
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.42
Resistance Level
$0.79
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.68
Wall Street Target
$12.00
(+1848.1%)
Share & Embed Analysis
Last updated: June 15, 2026 11:51 PM ET
Data refreshes hourly during market hours. Next update: 12:51 AM
Data refreshes hourly during market hours. Next update: 12:51 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 57 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 53 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$256 | 59 HOLD |
